Maika
2021-03-05
nice
3 Medtech Trends That Will Outlive the Pandemic<blockquote>将在大流行之后持续存在的3个医疗技术趋势</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":367134977,"tweetId":"367134977","gmtCreate":1614918868799,"gmtModify":1703482973637,"author":{"id":3574398921203400,"idStr":"3574398921203400","authorId":3574398921203400,"authorIdStr":"3574398921203400","name":"Maika","avatar":"https://static.tigerbbs.com/67b895886721e1132ca561323be59c05","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>nice</p></body></html>","htmlText":"<html><head></head><body><p>nice</p></body></html>","text":"nice","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/367134977","repostId":1138978257,"repostType":4,"repost":{"id":"1138978257","kind":"news","pubTimestamp":1614913165,"share":"https://www.laohu8.com/m/news/1138978257?lang=zh_CN&edition=full","pubTime":"2021-03-05 10:59","market":"us","language":"en","title":"3 Medtech Trends That Will Outlive the Pandemic<blockquote>将在大流行之后持续存在的3个医疗技术趋势</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138978257","media":"Nasdaq","summary":"Vaccines are starting to roll out in many parts of the world and some believe the beginning of the e","content":"<p>Vaccines are starting to roll out in many parts of the world and some believe the beginning of the end of the pandemic is in sight. Optimism is always welcome, but it’s important to acknowledge the challenges aren’t all behind us.</p><p><blockquote>疫苗开始在世界许多地方推广,一些人认为大流行即将结束。乐观总是受欢迎的,但重要的是要承认挑战并没有全部过去。</blockquote></p><p> Neither are the solutions to those challenges.</p><p><blockquote>这些挑战的解决方案也不是。</blockquote></p><p> Innovative and exciting medtech solutions emerged over the past year in attempts to address our pandemic-induced problems head on, particularly in the field of medical technology. Which of these technologies offer advantages that go beyond the inconveniences of social distancing, and provide permanent value once relative normality has returned?</p><p><blockquote>在过去的一年里,创新和令人兴奋的医疗技术解决方案出现了,试图正面解决我们的疫情引发的问题,特别是在医疗技术领域。这些技术中哪一项提供了超越社交距离不便的优势,并在相对正常恢复后提供永久价值?</blockquote></p><p> <b>Patient Safety</b></p><p><blockquote><b>患者安全</b></blockquote></p><p> While increased awareness of patient safety has made major strides in the last decade, COVID-19 has thrown the issue into the spotlight. It was 2016 when BMJ published a report citing medical errors as the third leading cause of death in the United States behind heart disease and cancer. The medical community took a brief moment to pause and reflect on how a certain proportion of human loss, through human error, is something we as a society have traditionally accepted. Now, we’re reflecting on patient safety again.</p><p><blockquote>虽然在过去十年中,患者安全意识的提高取得了重大进展,但新冠肺炎将这个问题推到了聚光灯下。2016年,BMJ发表了一份报告,称医疗差错是美国仅次于心脏病和癌症的第三大死亡原因。医学界花了一个短暂的时间停下来思考,由于人为错误,一定比例的人为损失是我们作为一个社会传统上接受的。现在,我们再次反思病人的安全。</blockquote></p><p> Social distancing, viral prevention, sanitation, and refined approaches to ICU patients all came to the fore during the height of the pandemic. Malnourishment among ICU patients, for instance, was a much more obscure concern before the pandemic. But with a rising number of patients requiring ICU support alongside more studies highlighting the dangers of malnourishment, medtech providers have developed unique methods to circumvent these dangers.</p><p><blockquote>社交距离、病毒预防、卫生设施和对ICU患者的改进方法都在疫情的高峰期脱颖而出。例如,在大流行之前,重症监护室患者的营养不良是一个更加模糊的问题。但随着越来越多的患者需要ICU支持,以及更多的研究强调营养不良的危险,医疗技术提供商开发了独特的方法来规避这些危险。</blockquote></p><p> Medical communities have even cultivated awareness campaigns to streamline the issue, with projects like the Patient Safety Movement, which aims to raise public awareness, expand clinical support, and create a wider sense of urgency surrounding the issue. The movement works to create and freely share actionable solutions (Actionable Patient Safety Solutions) to help mitigate potential dangers.</p><p><blockquote>医学界甚至开展了宣传活动来简化这一问题,如患者安全运动等项目,旨在提高公众意识,扩大临床支持,并围绕这一问题创造更广泛的紧迫感。该运动致力于创建和自由分享可操作的解决方案(可操作的患者安全解决方案),以帮助减轻潜在的危险。</blockquote></p><p> Publications such as the British Medical Journal had already red-flagged it as a serious concern long before the pandemic entered the frame. As such, the issue is unlikely to peter out once we’ve arrived at a point of greater normality.</p><p><blockquote>早在疫情进入框架之前,《英国医学杂志》等出版物就已经将其标记为严重问题。因此,一旦我们达到更正常的程度,这个问题就不太可能消失。</blockquote></p><p> <b>Telemedicine</b></p><p><blockquote><b>远程医疗</b></blockquote></p><p> Telemedicine is the very epitome of technology-driven healthcare and serves as a literal lifeline for millions of people who do not have access to proper medical facilities.</p><p><blockquote>远程医疗是技术驱动的医疗保健的缩影,是数百万无法获得适当医疗设施的人的生命线。</blockquote></p><p> In April of 2020, 43.5 percent of Medicare primary care visits utilized telehealth methods rather than in-person visits. One of the major benefits of telehealth over in-person alternatives is that it has reduced contact between patients, healthcare workers, and other patients—making it a fitting solution within social distancing guidelines. Wearable devices enable healthcare workers to have real-time information on patient data while they remain at home, such as physicians being updated remotely by people with diabetes regarding insulin dosages.</p><p><blockquote>2020年4月,43.5%的医疗保险初级保健就诊使用远程医疗方法,而不是亲自就诊。与面对面替代方案相比,远程医疗的主要优势之一是它减少了患者、医护人员和其他患者之间的接触,使其成为社交距离准则内的合适解决方案。可穿戴设备使医护人员能够在家中获得患者数据的实时信息,例如糖尿病患者远程更新医生的胰岛素剂量。</blockquote></p><p> Telemedicine will likely become part of the medtech furniture beyond the pandemic, since its benefits and usability achieved vindication through the necessity of circumstance.</p><p><blockquote>远程医疗可能会成为疫情以外的医疗技术家具的一部分,因为它的好处和可用性通过环境的必要性得到了证明。</blockquote></p><p> According to Mordor Intelligence, the industry will be worth more than $66 billion by 2021. It should be stressed that Telemedicine is not a product of 2020. It was being developed much prior and just like patient safety, the pandemic has acted as a wonderful springboard. In essence, telemedicine allows greater access to medical specialists while allowing medicine to treat more patients on a whole. Pandemic or no pandemic, this is a destination medicine will always strive for.</p><p><blockquote>根据Mordor Intelligence的数据,到2021年,该行业的价值将超过660亿美元。需要强调的是,远程医疗不是2020年的产物。它在很久以前就被开发出来了,就像病人安全一样,疫情是一个很好的跳板。从本质上讲,远程医疗允许更多地接触医学专家,同时允许医学在整体上治疗更多的患者。不管有没有疫情,这都是医学将永远努力的目标。</blockquote></p><p> <b>Deep Tech</b></p><p><blockquote><b>深度技术</b></blockquote></p><p> Digital technology is undeniably altering the way care is both accessed and delivered. 2020 has been a catalyst for this sphere—necessity is the mother of invention, and there has been plenty of necessary demand as of late.</p><p><blockquote>不可否认,数字技术正在改变获得和提供护理的方式。2020年是这一领域的催化剂——必要性是发明之母,最近有大量的必要需求。</blockquote></p><p> Deeptech is the generic term designated for technologies not focused on end-user services that includes artificial intelligence, robotics, blockchain, and advanced material science, as well as photonics and electronics, biotech and quantum computing. Deeptech exists as a disruptor with a difference. We think about it as the technology that allows us to transcend the status quo, since current technologies ultimately block progress and deeptech is acting as the un-blocker.</p><p><blockquote>Deeptech是不专注于最终用户服务的技术的通用术语,包括人工智能、机器人、区块链和先进材料科学,以及光子学和电子学、生物技术和量子计算。Deeptech作为一个与众不同的颠覆者而存在。我们认为它是让我们超越现状的技术,因为当前的技术最终会阻碍进步,而deeptech则充当了解除障碍的角色。</blockquote></p><p> Swati Chaturvedi, CEO of Propel, put it succinctly in an interview with Medtech Innovation:</p><p><blockquote>Propel首席执行官Swati Chaturvedi在接受Medtech Innovation采访时简洁地说道:</blockquote></p><p> “They are trying to solve big issues that really affect the world around them.. For example, a new medical device or technique fighting cancer.”</p><p><blockquote>“他们试图解决真正影响他们周围世界的大问题……例如,一种新的抗癌医疗设备或技术。”</blockquote></p><p></p><p> Deep Tech has been taken by the travails of COVID-19, since the effects of the virus represent the most pressing priority for medtech going into the new year. But it would be a mistake to view Deep Tech as some temporary trend, it represents the first step for medtech in one of the most comprehensive transitions of our technological and functional capacities.</p><p><blockquote>深度技术已经被新冠肺炎的阵痛所困扰,因为病毒的影响代表了医疗技术进入新的一年最紧迫的优先事项。但将深度技术视为某种暂时趋势是错误的,它代表着医疗技术在我们的技术和功能能力最全面的转变之一中迈出的第一步。</blockquote></p><p> It would be easy to explain away medtech’s activity in 2020 as a direct result of Covid, with trends arising to to address the challenges. The truth is a large proportion of the trends we are seeing now have been in the pipelines for some time, some for decades. In some cases, it's taken extraordinary global circumstances for medical trends to propel, but now that the global mindset is becoming digitized, more demanding, and wearier of potential disaster, such trends are unlikely to depart any time soon. People are anesthetized by familiarity, and it requires a year of extreme trepidation for our mindsets to embrace unconventionally effective solutions.</p><p><blockquote>很容易将医疗技术在2020年的活动解释为Covid的直接结果,并出现了应对挑战的趋势。事实是,我们现在看到的大部分趋势已经酝酿了一段时间,有些已经酝酿了几十年。在某些情况下,医学趋势需要非凡的全球环境才能推动,但现在全球思维正变得数字化,要求更高,对潜在灾难更加厌倦,这种趋势不太可能很快消失。人们被熟悉感麻醉了,我们的心态需要一年的极度恐惧才能接受非常规有效的解决方案。</blockquote></p><p> <i>About Author</i></p><p><blockquote><i>关于作者</i></blockquote></p><p> <i>Doron Besser, Chief Executive Officer: Doron Besser is the CEO of ENvizion Medical and Managing General Partner of Swing Medical. Prior to co-founding ENvizion with Shay Tsuker in 2013, Doron served as President and CEO of Angioslide Ltd., a company specializing in innovative, cost effective angioplasty products. Doron guided the company through its infancy stages, which included complicated animal and human trials, to FDA clearance, CE approval and initial market penetration in Europe and the US. Doron also served as VP of Clinical and Marketing and VP of Business Development at SuperDimension, a leader in minimally-invasive pulmonology devices. Doron holds a Doctor of Medicine from Ludwig Maximillians University in Munich, Germany.</i></p><p><blockquote><i>Doron Besser,首席执行官:Doron Besser是ENvizion Medical的首席执行官和Swing Medical的管理普通合伙人。在2013年与Shay Tsuker共同创立ENvizion之前,Doron曾担任Angioslide Ltd.的总裁兼首席执行官,该公司专门从事创新、经济高效的血管成形术产品。Doron指导该公司度过了包括复杂的动物和人体试验在内的婴儿阶段,直至FDA批准、CE批准以及在欧洲和美国的初步市场渗透。Doron还曾担任微创肺病设备领导者SuperDimension的临床和营销副总裁以及业务开发副总裁。多伦拥有德国慕尼黑路德维希马克西米利安大学的医学博士学位。</i></blockquote></p><p> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p><p><blockquote>本文表达的观点和意见是作者的观点和意见,不一定反映纳斯达克公司的观点和意见。</blockquote></p><p></p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Medtech Trends That Will Outlive the Pandemic<blockquote>将在大流行之后持续存在的3个医疗技术趋势</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Medtech Trends That Will Outlive the Pandemic<blockquote>将在大流行之后持续存在的3个医疗技术趋势</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Nasdaq</strong><span class=\"h-time small\">2021-03-05 10:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Vaccines are starting to roll out in many parts of the world and some believe the beginning of the end of the pandemic is in sight. Optimism is always welcome, but it’s important to acknowledge the challenges aren’t all behind us.</p><p><blockquote>疫苗开始在世界许多地方推广,一些人认为大流行即将结束。乐观总是受欢迎的,但重要的是要承认挑战并没有全部过去。</blockquote></p><p> Neither are the solutions to those challenges.</p><p><blockquote>这些挑战的解决方案也不是。</blockquote></p><p> Innovative and exciting medtech solutions emerged over the past year in attempts to address our pandemic-induced problems head on, particularly in the field of medical technology. Which of these technologies offer advantages that go beyond the inconveniences of social distancing, and provide permanent value once relative normality has returned?</p><p><blockquote>在过去的一年里,创新和令人兴奋的医疗技术解决方案出现了,试图正面解决我们的疫情引发的问题,特别是在医疗技术领域。这些技术中哪一项提供了超越社交距离不便的优势,并在相对正常恢复后提供永久价值?</blockquote></p><p> <b>Patient Safety</b></p><p><blockquote><b>患者安全</b></blockquote></p><p> While increased awareness of patient safety has made major strides in the last decade, COVID-19 has thrown the issue into the spotlight. It was 2016 when BMJ published a report citing medical errors as the third leading cause of death in the United States behind heart disease and cancer. The medical community took a brief moment to pause and reflect on how a certain proportion of human loss, through human error, is something we as a society have traditionally accepted. Now, we’re reflecting on patient safety again.</p><p><blockquote>虽然在过去十年中,患者安全意识的提高取得了重大进展,但新冠肺炎将这个问题推到了聚光灯下。2016年,BMJ发表了一份报告,称医疗差错是美国仅次于心脏病和癌症的第三大死亡原因。医学界花了一个短暂的时间停下来思考,由于人为错误,一定比例的人为损失是我们作为一个社会传统上接受的。现在,我们再次反思病人的安全。</blockquote></p><p> Social distancing, viral prevention, sanitation, and refined approaches to ICU patients all came to the fore during the height of the pandemic. Malnourishment among ICU patients, for instance, was a much more obscure concern before the pandemic. But with a rising number of patients requiring ICU support alongside more studies highlighting the dangers of malnourishment, medtech providers have developed unique methods to circumvent these dangers.</p><p><blockquote>社交距离、病毒预防、卫生设施和对ICU患者的改进方法都在疫情的高峰期脱颖而出。例如,在大流行之前,重症监护室患者的营养不良是一个更加模糊的问题。但随着越来越多的患者需要ICU支持,以及更多的研究强调营养不良的危险,医疗技术提供商开发了独特的方法来规避这些危险。</blockquote></p><p> Medical communities have even cultivated awareness campaigns to streamline the issue, with projects like the Patient Safety Movement, which aims to raise public awareness, expand clinical support, and create a wider sense of urgency surrounding the issue. The movement works to create and freely share actionable solutions (Actionable Patient Safety Solutions) to help mitigate potential dangers.</p><p><blockquote>医学界甚至开展了宣传活动来简化这一问题,如患者安全运动等项目,旨在提高公众意识,扩大临床支持,并围绕这一问题创造更广泛的紧迫感。该运动致力于创建和自由分享可操作的解决方案(可操作的患者安全解决方案),以帮助减轻潜在的危险。</blockquote></p><p> Publications such as the British Medical Journal had already red-flagged it as a serious concern long before the pandemic entered the frame. As such, the issue is unlikely to peter out once we’ve arrived at a point of greater normality.</p><p><blockquote>早在疫情进入框架之前,《英国医学杂志》等出版物就已经将其标记为严重问题。因此,一旦我们达到更正常的程度,这个问题就不太可能消失。</blockquote></p><p> <b>Telemedicine</b></p><p><blockquote><b>远程医疗</b></blockquote></p><p> Telemedicine is the very epitome of technology-driven healthcare and serves as a literal lifeline for millions of people who do not have access to proper medical facilities.</p><p><blockquote>远程医疗是技术驱动的医疗保健的缩影,是数百万无法获得适当医疗设施的人的生命线。</blockquote></p><p> In April of 2020, 43.5 percent of Medicare primary care visits utilized telehealth methods rather than in-person visits. One of the major benefits of telehealth over in-person alternatives is that it has reduced contact between patients, healthcare workers, and other patients—making it a fitting solution within social distancing guidelines. Wearable devices enable healthcare workers to have real-time information on patient data while they remain at home, such as physicians being updated remotely by people with diabetes regarding insulin dosages.</p><p><blockquote>2020年4月,43.5%的医疗保险初级保健就诊使用远程医疗方法,而不是亲自就诊。与面对面替代方案相比,远程医疗的主要优势之一是它减少了患者、医护人员和其他患者之间的接触,使其成为社交距离准则内的合适解决方案。可穿戴设备使医护人员能够在家中获得患者数据的实时信息,例如糖尿病患者远程更新医生的胰岛素剂量。</blockquote></p><p> Telemedicine will likely become part of the medtech furniture beyond the pandemic, since its benefits and usability achieved vindication through the necessity of circumstance.</p><p><blockquote>远程医疗可能会成为疫情以外的医疗技术家具的一部分,因为它的好处和可用性通过环境的必要性得到了证明。</blockquote></p><p> According to Mordor Intelligence, the industry will be worth more than $66 billion by 2021. It should be stressed that Telemedicine is not a product of 2020. It was being developed much prior and just like patient safety, the pandemic has acted as a wonderful springboard. In essence, telemedicine allows greater access to medical specialists while allowing medicine to treat more patients on a whole. Pandemic or no pandemic, this is a destination medicine will always strive for.</p><p><blockquote>根据Mordor Intelligence的数据,到2021年,该行业的价值将超过660亿美元。需要强调的是,远程医疗不是2020年的产物。它在很久以前就被开发出来了,就像病人安全一样,疫情是一个很好的跳板。从本质上讲,远程医疗允许更多地接触医学专家,同时允许医学在整体上治疗更多的患者。不管有没有疫情,这都是医学将永远努力的目标。</blockquote></p><p> <b>Deep Tech</b></p><p><blockquote><b>深度技术</b></blockquote></p><p> Digital technology is undeniably altering the way care is both accessed and delivered. 2020 has been a catalyst for this sphere—necessity is the mother of invention, and there has been plenty of necessary demand as of late.</p><p><blockquote>不可否认,数字技术正在改变获得和提供护理的方式。2020年是这一领域的催化剂——必要性是发明之母,最近有大量的必要需求。</blockquote></p><p> Deeptech is the generic term designated for technologies not focused on end-user services that includes artificial intelligence, robotics, blockchain, and advanced material science, as well as photonics and electronics, biotech and quantum computing. Deeptech exists as a disruptor with a difference. We think about it as the technology that allows us to transcend the status quo, since current technologies ultimately block progress and deeptech is acting as the un-blocker.</p><p><blockquote>Deeptech是不专注于最终用户服务的技术的通用术语,包括人工智能、机器人、区块链和先进材料科学,以及光子学和电子学、生物技术和量子计算。Deeptech作为一个与众不同的颠覆者而存在。我们认为它是让我们超越现状的技术,因为当前的技术最终会阻碍进步,而deeptech则充当了解除障碍的角色。</blockquote></p><p> Swati Chaturvedi, CEO of Propel, put it succinctly in an interview with Medtech Innovation:</p><p><blockquote>Propel首席执行官Swati Chaturvedi在接受Medtech Innovation采访时简洁地说道:</blockquote></p><p> “They are trying to solve big issues that really affect the world around them.. For example, a new medical device or technique fighting cancer.”</p><p><blockquote>“他们试图解决真正影响他们周围世界的大问题……例如,一种新的抗癌医疗设备或技术。”</blockquote></p><p></p><p> Deep Tech has been taken by the travails of COVID-19, since the effects of the virus represent the most pressing priority for medtech going into the new year. But it would be a mistake to view Deep Tech as some temporary trend, it represents the first step for medtech in one of the most comprehensive transitions of our technological and functional capacities.</p><p><blockquote>深度技术已经被新冠肺炎的阵痛所困扰,因为病毒的影响代表了医疗技术进入新的一年最紧迫的优先事项。但将深度技术视为某种暂时趋势是错误的,它代表着医疗技术在我们的技术和功能能力最全面的转变之一中迈出的第一步。</blockquote></p><p> It would be easy to explain away medtech’s activity in 2020 as a direct result of Covid, with trends arising to to address the challenges. The truth is a large proportion of the trends we are seeing now have been in the pipelines for some time, some for decades. In some cases, it's taken extraordinary global circumstances for medical trends to propel, but now that the global mindset is becoming digitized, more demanding, and wearier of potential disaster, such trends are unlikely to depart any time soon. People are anesthetized by familiarity, and it requires a year of extreme trepidation for our mindsets to embrace unconventionally effective solutions.</p><p><blockquote>很容易将医疗技术在2020年的活动解释为Covid的直接结果,并出现了应对挑战的趋势。事实是,我们现在看到的大部分趋势已经酝酿了一段时间,有些已经酝酿了几十年。在某些情况下,医学趋势需要非凡的全球环境才能推动,但现在全球思维正变得数字化,要求更高,对潜在灾难更加厌倦,这种趋势不太可能很快消失。人们被熟悉感麻醉了,我们的心态需要一年的极度恐惧才能接受非常规有效的解决方案。</blockquote></p><p> <i>About Author</i></p><p><blockquote><i>关于作者</i></blockquote></p><p> <i>Doron Besser, Chief Executive Officer: Doron Besser is the CEO of ENvizion Medical and Managing General Partner of Swing Medical. Prior to co-founding ENvizion with Shay Tsuker in 2013, Doron served as President and CEO of Angioslide Ltd., a company specializing in innovative, cost effective angioplasty products. Doron guided the company through its infancy stages, which included complicated animal and human trials, to FDA clearance, CE approval and initial market penetration in Europe and the US. Doron also served as VP of Clinical and Marketing and VP of Business Development at SuperDimension, a leader in minimally-invasive pulmonology devices. Doron holds a Doctor of Medicine from Ludwig Maximillians University in Munich, Germany.</i></p><p><blockquote><i>Doron Besser,首席执行官:Doron Besser是ENvizion Medical的首席执行官和Swing Medical的管理普通合伙人。在2013年与Shay Tsuker共同创立ENvizion之前,Doron曾担任Angioslide Ltd.的总裁兼首席执行官,该公司专门从事创新、经济高效的血管成形术产品。Doron指导该公司度过了包括复杂的动物和人体试验在内的婴儿阶段,直至FDA批准、CE批准以及在欧洲和美国的初步市场渗透。Doron还曾担任微创肺病设备领导者SuperDimension的临床和营销副总裁以及业务开发副总裁。多伦拥有德国慕尼黑路德维希马克西米利安大学的医学博士学位。</i></blockquote></p><p> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p><p><blockquote>本文表达的观点和意见是作者的观点和意见,不一定反映纳斯达克公司的观点和意见。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.nasdaq.com/articles/3-medtech-trends-that-will-outlive-the-pandemic-2021-03-04\">Nasdaq</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/3-medtech-trends-that-will-outlive-the-pandemic-2021-03-04","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138978257","content_text":"Vaccines are starting to roll out in many parts of the world and some believe the beginning of the end of the pandemic is in sight. Optimism is always welcome, but it’s important to acknowledge the challenges aren’t all behind us.\nNeither are the solutions to those challenges.\nInnovative and exciting medtech solutions emerged over the past year in attempts to address our pandemic-induced problems head on, particularly in the field of medical technology. Which of these technologies offer advantages that go beyond the inconveniences of social distancing, and provide permanent value once relative normality has returned?\nPatient Safety\nWhile increased awareness of patient safety has made major strides in the last decade, COVID-19 has thrown the issue into the spotlight. It was 2016 when BMJ published a report citing medical errors as the third leading cause of death in the United States behind heart disease and cancer. The medical community took a brief moment to pause and reflect on how a certain proportion of human loss, through human error, is something we as a society have traditionally accepted. Now, we’re reflecting on patient safety again.\nSocial distancing, viral prevention, sanitation, and refined approaches to ICU patients all came to the fore during the height of the pandemic. Malnourishment among ICU patients, for instance, was a much more obscure concern before the pandemic. But with a rising number of patients requiring ICU support alongside more studies highlighting the dangers of malnourishment, medtech providers have developed unique methods to circumvent these dangers.\nMedical communities have even cultivated awareness campaigns to streamline the issue, with projects like the Patient Safety Movement, which aims to raise public awareness, expand clinical support, and create a wider sense of urgency surrounding the issue. The movement works to create and freely share actionable solutions (Actionable Patient Safety Solutions) to help mitigate potential dangers.\nPublications such as the British Medical Journal had already red-flagged it as a serious concern long before the pandemic entered the frame. As such, the issue is unlikely to peter out once we’ve arrived at a point of greater normality.\nTelemedicine\nTelemedicine is the very epitome of technology-driven healthcare and serves as a literal lifeline for millions of people who do not have access to proper medical facilities.\nIn April of 2020, 43.5 percent of Medicare primary care visits utilized telehealth methods rather than in-person visits. One of the major benefits of telehealth over in-person alternatives is that it has reduced contact between patients, healthcare workers, and other patients—making it a fitting solution within social distancing guidelines. Wearable devices enable healthcare workers to have real-time information on patient data while they remain at home, such as physicians being updated remotely by people with diabetes regarding insulin dosages.\nTelemedicine will likely become part of the medtech furniture beyond the pandemic, since its benefits and usability achieved vindication through the necessity of circumstance.\nAccording to Mordor Intelligence, the industry will be worth more than $66 billion by 2021. It should be stressed that Telemedicine is not a product of 2020. It was being developed much prior and just like patient safety, the pandemic has acted as a wonderful springboard. In essence, telemedicine allows greater access to medical specialists while allowing medicine to treat more patients on a whole. Pandemic or no pandemic, this is a destination medicine will always strive for.\nDeep Tech\nDigital technology is undeniably altering the way care is both accessed and delivered. 2020 has been a catalyst for this sphere—necessity is the mother of invention, and there has been plenty of necessary demand as of late.\nDeeptech is the generic term designated for technologies not focused on end-user services that includes artificial intelligence, robotics, blockchain, and advanced material science, as well as photonics and electronics, biotech and quantum computing. Deeptech exists as a disruptor with a difference. We think about it as the technology that allows us to transcend the status quo, since current technologies ultimately block progress and deeptech is acting as the un-blocker.\nSwati Chaturvedi, CEO of Propel, put it succinctly in an interview with Medtech Innovation:\n“They are trying to solve big issues that really affect the world around them.. For example, a new medical device or technique fighting cancer.”\nDeep Tech has been taken by the travails of COVID-19, since the effects of the virus represent the most pressing priority for medtech going into the new year. But it would be a mistake to view Deep Tech as some temporary trend, it represents the first step for medtech in one of the most comprehensive transitions of our technological and functional capacities.\nIt would be easy to explain away medtech’s activity in 2020 as a direct result of Covid, with trends arising to to address the challenges. The truth is a large proportion of the trends we are seeing now have been in the pipelines for some time, some for decades. In some cases, it's taken extraordinary global circumstances for medical trends to propel, but now that the global mindset is becoming digitized, more demanding, and wearier of potential disaster, such trends are unlikely to depart any time soon. People are anesthetized by familiarity, and it requires a year of extreme trepidation for our mindsets to embrace unconventionally effective solutions.\nAbout Author\nDoron Besser, Chief Executive Officer: Doron Besser is the CEO of ENvizion Medical and Managing General Partner of Swing Medical. Prior to co-founding ENvizion with Shay Tsuker in 2013, Doron served as President and CEO of Angioslide Ltd., a company specializing in innovative, cost effective angioplasty products. Doron guided the company through its infancy stages, which included complicated animal and human trials, to FDA clearance, CE approval and initial market penetration in Europe and the US. Doron also served as VP of Clinical and Marketing and VP of Business Development at SuperDimension, a leader in minimally-invasive pulmonology devices. Doron holds a Doctor of Medicine from Ludwig Maximillians University in Munich, Germany.\nThe views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1213,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/367134977"}
精彩评论